Skip to main content
. Author manuscript; available in PMC: 2015 Nov 30.
Published in final edited form as: Clin Pharmacol Ther. 2015 Sep;98(3):321–327. doi: 10.1002/cpt.150

Table 4.

Testing and Validation of the loratadine/simvastatin interaction using case-only datasets

Data Sets Odds Ratio 95% CI N12 N1 N2 N00
INPC CDM 1.53 (1.28, 1.82) 37 1,264 4,197 5,572
FAERS 2.20 (2.02, 3.65) 37 276 6,116 100,531

N12, N1, N2 and N00 is the number of myopathy cases with prescription for both simvastatin and loratadine, simvastatin only, loratadine only, and neither drug, respectively. INPC CDM stands for Indiana Network of Patient Care Common Data Model. FAERS stands for the FDA adverse event reporting system